Quanterix
UltraDx Bio Receives Chinese Clinical Registration Approval for UD-X Immunoassay Analyzer
With the approval, the UD-X analyzer, which uses Quanterix's single-molecule array technology, can be used for clinical applications in China.
Davos Alzheimer's Collaborative Creates Initiative to Improve Alzheimer's Diagnosis
Under the program, blood biomarkers and confirmatory diagnostic testing will be used to increase diagnosis of Alzheimer’s disease and related dementias.
Two studies, led by researchers at Oxford and University College London, aim to explore whether blood-based markers can speed up diagnoses and improve outcomes.
In Brief This Week: A2 Biotherapeutics, Ellipses Pharma, Quanterix, Verismo Therapeutics
News items for the week of March 4, 2024.
Many firms in the space have developed or are developing tests for the marker, which shows great promise for detecting brain amyloid pathology.